Yeah. Merck. That's the ticket.

I'm sure there will be a PR any year now.

It's so good, right? Let's sign a deal with a partner to develop it then.

Into the ground in our case and left us with that cling-on Harness.

I'm actually sorry to see you have soured on IPIX. I was holding out hope that some of you stalwarts would get it right and I could get out above $0.10.

Why would he?

Anything you say or do can and will be used against you in a court of law.

He has enough money to coast out to retirement and gamble on BeaMed. Shareholders are no longer necessary. It's effectively a private company now more than ever.

He hit a home run alright. Anil would be proud.



By assets he means all those shareholder dollars. We're getting out of Beverly, Helen! To Boca we go!

Why would he do that? The purpose of the company is to pay him a salary. The Boca lifestyle ain't cheap.

We knew what this was as soon as he pulled his loan money out of the company. All upside, but only for Leo and Jane.

Isn't that sickening?

The "VP of Clinical Sciences and Portfolio Management" of this company deserves a bonus of any kind? What has gone right in the clinic, with the portfolio, or with the share price since she has come on board?

They aren't meaningless noise at all.

The signal is crystal clear. Every time a peer review article comes out in place of a deal our stock price descends decidedly within six months.

Uh huh.

Just like Dr. Frey

and Dr. Jorgenson

and Dr. Sonis

and Dr. Bertolino

and

So is it more likely that none of the dozen largest pharmas wanted to kick Leo a billion or two for Brilacidin and instead are united in having the FDA keep Brilacidin off the market

or

Is it more likely we've been scammed by a pink sheets CEO from Boca who also happened to be the CFO of Nanoviricides?

Asking for a friend.

You don't specify which company. Is it your company where you are both Investor Relations and Licensing and you will discuss B at your April meeting?

You're statement insinuates much but actually says nothing at all.

We can determine what her intent was but that does not good in court.

I can't actually decipher what statement is being made. Therefore, it cannot be determined if the statement is true or false.

"Director Investor Relations in the EU company confirms contact with the Licensing responsible and the plan to discuss Ipix B product in a meeting this month."

What is "the Licensing responsible"?

I can sum it up.

It's not securities fraud if it's just grammatically damaged enough to be gibberish in a legal sense.

Right. Where's the deal? We've been waiting on a partnership since 2015.

I got scammed. The people who told me I was getting scammed should be sentenced to death.

Gotcha.

Goes to show you how BeaMed values itself if it sold 41.6% of itself for $4 million.

We got Brilacidin for $5M as well. Leo's track record for being wiser than the market price is not a strong one.

But then...success is in the eye of the man getting a salary.

Why, that's exactly the number of shares that need to be sold at 0.021/share in order to fund Leo's salary for one year.

Hmmmm

That's tough to conclude since we have virtually no data on BeaMed.

Let's agree with you.

Then you have to ask yourself come June why he hasn't bought his shares back.

I didn't.

I compared a $12M OTC company (IPIX) with very limited resources and a handful of employees to a private company with very limited resources and handful of employees (BeaMed) that recently valued itself around $12M (they sold us 33% for $4M) in the purchase we made.

Who said anything about NASDAQ or any company fit for listing there? Neither of the companies I was discussing fits that bill.

They sold us 1/3 of the company for $4M.

That's the kind of deal IPIX would sign. They can't be doing that well.

We rich yet?

The filing told you what happened. We're not doing much clinical development on B until we get money from the BeaMed investment.

IPIX is now a public proxy stock for BeaMed the private company.

Ironically we bought 1/3 of BeaMed for $4M suggesting a $12M value for all of BeaMed.

IPIX is currently valued at $12M.

Unfortunately the truth is in the patent life. BeaMed income will support Leo's salary for many years to come but B will die on the vine.

You think Leo being dictator for life of IPIX reduces shareholder risk?

Have you seen what they guy has done to shareholders the past eight years?

99.5% loss for shares bought in January 2015.

Screw that monkey. Last time I saw him I was buying CTIX at $3.30/share.

Yes. Just around the corner.

Really? I though we just needed more university research.

He already has the 5-7 years of salary in the bank.

Well...at least that gives us a chance at success.

Hound - answer me this:

If you had to wager $4M on one of two options, which would you pick?

A) Moshe and Gil at BeaMed
B) Leo and Jane at IPIX

I'd go with with the light sabers too.

Get real cynical and assume both are complete frauds. Which one has completely exhausted all good will with the investment community? BeaMed at least has a chance at an IPO and moon pump to get us out.

Maybe I'm feeling charitable in the new year but perhaps Leo has simply and genuinely embraced his limitations.

Yeah but what if Moshe and Gil need another payday advance and all the cash is tied up in bonds?

You have to look at it from Leo's perspective. Does 4.5% matter? He's here for the salary...he can just issue more shares if he feels like it. The stock price and out standing share count doesn't matter. What are shareholders going to do? Vote No on the share authorization and let the company run out of money?

$500K/year is $500K/year even if IPIX has a billion shares at $0.001.

What do you mean? That money is there to retain Leo and Jane's expertise for another 5-7 years.

You think this company is going to drop another 99% all by itself without their help?

That knowledge helped IPIX go from a $500M company to a $10M company and we only needed to burn $100M of shareholder investment monies to get there.

Some of us have been looking forward at the many exciting opportunities for 7, 8, even 9 years now. At some point you have to look back and realize it's not going to happen.

I'm coming up on eight years in a few months. The shares I purchased prior to 2018 are all down about 99%. Even my latest purchase at 0.08 following the COVID trial failure are down over 75% in just over a year.



You can't possibly believe this at this point.

It's easy to tell. It's the same thing we have always been investing in.

The prosperity of the Ehrlich line.

My only question is when is Leo is going to hand this sled off to one of his kids?

It's extremely difficult to value BeaMed as it is private. I am extremely concerned about it and eagerly await finding out if this is a legitimate investment that bears fruit for us desperate shareholders.

I would be much more upset if our pharma pipeline had any real potential. I guess an unknown, hopeful gamble is better than betting on a nearly known failure that no BP seems to want a piece of for any significant sum of money..

Not true. Leo was sighted at the Publix at Garden Shops in Boca a few months back.

It's all fallen into place for ol' Leo.

A few universities and government labs will putz around with Brilacidin for a few more years and shareholders will wait on Alfasigma and BeaMed to hopefully do something.

All the while Leo can just crank out four boilerplate 10Q/Ks per year at $125K/pop all the way to retirement.

Don't forget the BeaMed Jewish light sabers. They might be good for fighting back COVID.

We are a holding company for 35% of BeaMed now. Brilacidin is largely in the past and will remain so until we (hopefully) get enough revenue from the light sabers to push onward. Hopefully the revenue will be more than enough to pay for just Leo's salary and whomever he hands the reigns to in the coming decades.

Things are looking up for the Ehrlich kids, no so much for the kids of IPIX shareholders.

Your rebuttal said essentially that. Forgive my punctuation.

So allow me to paraphrase that: "This is not a lifestyle company because Leo's free shares will make him generational wealth if the stock goes up 400x ($8/share "high single") to 800x ($16/share "mediocre double digits")."

In other words: "Leo has so much to gain on the upside that this can't possibly be a lifestyle company."

Which is probably exactly what he wants you to believe.

Not your quotes, but a breakdown and clarification of what you said so that everyone can understand how absurd this notion is. Allow me to elaborate:

Over the last 10 years, at various points, IPIX did a temporary 3x on hype and promptly corrected back down to lower than the start of the hype cycle. Then you come in and start saying it's not a lifestyle company because Leo would be rich if it goes up 400-800x.

Any you're worried about my paraphrasing of your statement? Hah!